Andembry

Active Ingredient(s): Garadacimab-gxii
FDA Approved: * June 16, 2025
Pharm Company: * CSL BEHRING LLC
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Andembry 200 mg/1.2ml Subcutaneous Injection, Solution
NDC: 63833-925
Labeler:
Csl